ENTEROCOCCAL SUPERINFECTION IN PATIENTS TREATED WITH CIPROFLOXACIN

被引:43
作者
ZERVOS, MJ
BACON, AE
PATTERSON, JE
SCHABERG, DR
KAUFFMAN, CA
机构
[1] UNIV MICHIGAN,VET ADM MED CTR,SCH MED,DEPT INTERNAL MED,DIV INFECT DIS,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,VET ADM MED CTR,SCH MED,DEPT LAB MED,DIV INFECT DIS,ANN ARBOR,MI 48109
关键词
D O I
10.1093/jac/21.1.113
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:113 / 115
页数:3
相关论文
共 6 条
[1]   CLINICAL-EXPERIENCE WITH CIPROFLOXACIN IN THE USA [J].
ARCIERI, G ;
AUGUST, R ;
BECKER, N ;
DOYLE, C ;
GRIFFITH, E ;
GRUENWALDT, G ;
HEYD, A ;
OBRIEN, B .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :220-225
[2]   ANTIBACTERIAL ACTIVITIES OF CIPROFLOXACIN, NORFLOXACIN, OXOLINIC ACID, CINOXACIN, AND NALIDIXIC-ACID [J].
BARRY, AL ;
JONES, RN ;
THORNSBERRY, C ;
AYERS, LW ;
GERLACH, EH ;
SOMMERS, HM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) :633-637
[3]   INVITRO AND INVIVO ACTIVITY OF CIPROFLOXACIN AGAINST ENTEROCOCCI ISOLATED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS [J].
FERNANDEZGUERRERO, M ;
ROUSE, MS ;
HENRY, NK ;
GERACI, JE ;
WILSON, WR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) :430-433
[4]  
GOMBERT ME, 1985, J ANTIMICROB CHEMOTH, V16, P709, DOI 10.1093/jac/16.6.709
[5]  
Jones R., 1985, MANUAL CLIN MICROBIO, P972
[6]  
REEVES DS, 1976, SELECTED TOPICS CLIN, P21